Simulation Used in Conjunction with Randomised Control Trials to Evaluate the Costs and Benefits of a New Drug. - Ruth Davies; Paul Roderick (WSC, 1998)

Planning resources for renal services throughout UK using simulation. - Ruth Davies; Paul Roderick (Eur. J. Oper. Res., 1998)

Using simulation modelling for evaluating screening services for diabetic retinopathy. - Ruth Davies; Sally C. Brailsford; Paul Roderick; Chris Canning; D. Crabbe (J. Oper. Res. Soc., 2000)

The evaluation of disease prevention and treatment using simulation models. - Ruth Davies; Paul Roderick; James P. Raftery (Eur. J. Oper. Res., 2003)

Use of a coronary heart disease simulation model to evaluate the costs and effectiveness of drugs for the prevention of heart disease. - Keith Cooper; Ruth Davies; James P. Raftery; Paul Roderick (J. Oper. Res. Soc., 2008)

Using a linked database for epidemiology across the primary and secondary care divide: acute kidney injury. - Matthew Johnson 010; Hilda Hounkpatin; Simon Fraser; David Culliford; Mark Uniacke; Paul Roderick (BMC Medical Informatics Decis. Mak., 2017)

Hybrid simulation modelling for dementia care services planning. - Dave Evenden; Sally C. Brailsford; C. M. Kipps; Paul Roderick; B. Walsh (J. Oper. Res. Soc., 2021)